Information
As the EU prioritizes preventive healthcare for the next decade, CheckEye is revolutionizing early disease detection with cutting-edge AI technology. Our MedTech platform enables rapid, affordable mass screening for over 10 chronic diseases, including diabetic retinopathy and hypertension, by analyzing vascular changes in the retina.
Delivering precise results in under 60 seconds, CheckEye empowers non-medical personnel to facilitate early intervention, making high-quality diagnostics accessible beyond traditional clinical settings. By partnering with primary care providers and pharmacies, we extend vital healthcare services to underserved communities worldwide, supporting UN Sustainable Development Goal #3.
CheckEye is the 2024 EIT Health InnoStars Winner.
Delivering precise results in under 60 seconds, CheckEye empowers non-medical personnel to facilitate early intervention, making high-quality diagnostics accessible beyond traditional clinical settings. By partnering with primary care providers and pharmacies, we extend vital healthcare services to underserved communities worldwide, supporting UN Sustainable Development Goal #3.
CheckEye is the 2024 EIT Health InnoStars Winner.
Key Information
-
Pre-Seed
Growth Stage
-
CountryUkraine
-
Founding Year2022